Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion description "[Inhibitors of the PI3K pathway are in clinical testing in patients with solid tumors, including uterine cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion evidence source_evidence_literature NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion SIO_000772 21903247 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion wasDerivedFrom befree-20140225 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_assertion wasGeneratedBy ECO_0000203 NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP714586.RAxJ20XJDOCK1EaY_nmZNU0v4pT_t-gkV3IcM1WhGisdg130_provenance.